Keeping vernix on newborns to prevent eczema
Part of Genetic & congenital, Immune system & allergy, Infections, Skin clinical trials.
This study tests whether leaving the white, waxy coating (vernix caseosa) on a newborn’s skin after birth can help prevent the development of eczema (atopic dermatitis) in early childhood. It compares standard bathing practices with preserving this natural skin barrier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a pregnant woman 18 years or older
- You are carrying one healthy baby (not twins or more)
- Your baby is born at or later than 34 weeks of pregnancy
- Your baby weighs at least 2000 grams (about 4.4 pounds) at birth
- You are not HIV-positive
- You do not have chorioamnionitis or plan to have your baby hospitalized immediately after birth
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny skin samples from babies to find clues about eczema. It uses a gentle, painless device that sucks up a small piece of skin. If your baby has eczema or is healthy and under 6 months old, you may be able to join.
This study looks at whether restoring a newborn’s gut bacteria (microbiome) can improve early health. Babies are treated based on the birth conditions, especially whether delivery was vaginal or by C-section.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This study compares the health of mothers and their babies in two groups: women with eczema who used ruxolitinib cream during pregnancy and those who did not. It aims to see if the cream is safe for both mother and child.
This study tests whether removing a type of bacteria (staph) from the skin can reduce the severity of atopic dermatitis (eczema). It may help people with moderate to severe eczema who have not used certain treatments recently.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.